NewPro3D
Develops ultra-fast DLP 3D printers using Intelligent Liquid Interface (ILI) technology for photopolymer printing, targeting medical and engineering applications.
- CEO / Founder
- Brian Rock
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $12.5M
- Latest Round
- Venture Round
- Key Investors
- PBYVentures
Technology & Products
Key Products
NP1 DLP 3D Printer; NP1-L DLP 3D Printer
Technological Advantage
Proprietary ILI process enables 30% faster printing than competitors, with verified speeds printing a full-sized skull in minutes vs hours; defensible through R&D and membrane formulations.
Differentiation
Value Proposition
Reduces 3D printing time by up to 150x compared to traditional SLA and 40x vs PolyJet, enabling rapid production of anatomical models and end-use parts for surgical planning and prototyping.
How They Differentiate
3x faster than traditional DLP/SLA printers (55 mm in 4.3 min vs 18+ hours for FDM), with ILI technology reducing pull force vs competitors' oxygen or pneumatic systems; focuses on medical applications with Henkel/BASF material partnerships.
Market & Competition
Target Customers
Medical device manufacturers, hospitals, universities, engineering firms
Industry Verticals
Medical; Engineering; Education
Competitors
NEXA3D; Carbon3D; HP (Multi Jet Fusion)
Growth & Milestones
Growth Metrics
Annual revenue was $4 million in 2025
Major Milestones
2015: Founded and ILI technology development; 2016: Showcased at CES with fast printing demos; 2018: NP1 printer commercially available; 2020: Partnership with Henkel for medical 3D printing
Notable Customers
Formula UBC Racing; Stanford University; University of Washington; University of Louisville